UPDATED Apr 23, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$407.06 | -1.8% | 47.8% | US$3.0t | US$471.24 | PE36.6x | E12.6% | 0.7% | Software | ||
GOOGL | US$158.27 | 2.5% | 52.4% | US$2.0t | US$166.83 | PE26.7x | E11.8% | n/a | Media | ||
2330 | NT$754.00 | -4.3% | 51.4% | NT$19.6t | NT$912.98 | PE22.8x | E16.1% | 1.9% | Semiconductors | ||
NOVO B | kr.891.30 | 2.7% | 54.4% | kr.4.0t | kr.904.20 | PE47.5x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
CRM | US$276.68 | -0.3% | 45.1% | US$265.6b | US$335.22 | PE64.9x | E18.7% | 0.6% | Software | ||
ADBE | US$472.92 | -0.7% | 28.0% | US$209.2b | US$617.38 | PE44.1x | E17.1% | n/a | Software | ||
ROG | CHF229.70 | 3.7% | -18.5% | CHF185.3b | CHF281.06 | PE15.9x | E8.2% | 4.2% | Pharmaceuticals & Biotech | ||
NOVN | CHF88.94 | 4.6% | -4.5% | CHF181.5b | CHF97.99 | PE21.9x | E10.0% | 3.7% | Pharmaceuticals & Biotech | ||
AXP | US$238.96 | 9.4% | 53.1% | US$167.6b | US$220.17 | PE19.4x | E7.6% | 1.2% | Diversified Financials | ||
PDD | US$128.03 | 12.8% | 98.3% | US$164.9b | US$179.84 | PE20.5x | E23.0% | n/a | Retail | ||
AIR | €162.72 | 2.3% | 29.2% | €128.1b | €175.62 | PE33.8x | E17.7% | 1.1% | Capital Goods | ||
VRTX | US$404.91 | 2.7% | 22.0% | US$103.4b | US$460.34 | PE28.9x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
SAF | €209.00 | 2.0% | 47.1% | €86.4b | €206.26 | PE25.1x | E5.8% | 1.1% | Capital Goods | ||
CSL | AU$278.97 | 1.6% | -8.3% | AU$134.8b | AU$308.96 | PE35.2x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
CFR | CHF129.35 | 1.1% | -14.0% | CHF76.0b | CHF146.09 | PE19.6x | E7.8% | 2.7% | Consumer Durables | ||
SLB | US$49.55 | -3.6% | 1.2% | US$70.8b | US$67.11 | PE16.3x | E13.4% | 2.2% | Energy | ||
CRWD | US$299.65 | 0.2% | 145.3% | US$69.9b | US$390.62 | PE811.4x | E34.4% | n/a | Software | ||
1299 | HK$48.75 | 6.0% | -41.1% | HK$545.9b | HK$94.97 | PE18.5x | E17.9% | 3.3% | Insurance | ||
NTES | US$93.07 | 2.9% | 10.1% | US$59.3b | US$133.02 | PE14.3x | E7.9% | 2.7% | Media | ||
BBRI | Rp5,300.00 | -0.9% | 7.1% | Rp799.2t | Rp6,681.54 | PB2.6x | E11.3% | 6.0% | Banks | ||
300760 | CN¥284.50 | 6.2% | -6.0% | CN¥344.1b | CN¥396.59 | PE30.3x | E15.0% | 3.0% | Healthcare | ||
2454 | NT$972.00 | -7.9% | 49.5% | NT$1.5t | NT$1,200.95 | PE20.1x | E14.0% | 6.3% | Semiconductors | ||
CPNG | US$22.72 | 0.9% | 44.8% | US$40.3b | US$22.41 | PE30x | E7.0% | n/a | Retail | ||
ALC | CHF73.78 | 1.2% | 14.1% | CHF36.4b | CHF84.95 | PE41x | E10.5% | 0.3% | Healthcare |